Dihydroergocornine
Chemical compound
![]() |
|
Names | |
---|---|
IUPAC name
(10α
H
)-12′-Hydroxy-2′,5′α-di(propan-2-yl)-9,10-dihydroergotaman-3′,6′,18-trione
|
|
Systematic IUPAC name
(6a
R
,9
R
,10a
R
)-
N
-[(2
R
,5
S
,10a
S
,10b
S
)-10b-Hydroxy-3,6-oxo-2,5-di(propan-2-yl)-octahydro-8
H
-[1,3]oxazolo[3,2-
a
]pyrrolo[2,1-
c
]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-
fg
]quinoline-9-carboxamide
|
|
Identifiers | |
3D model (
JSmol
)
|
|
ChemSpider |
|
ECHA InfoCard |
100.042.705
![]() |
PubChem
CID
|
|
UNII | |
CompTox Dashboard
(
EPA
)
|
|
|
|
|
|
Properties | |
C 31 H 41 N 5 O 5 | |
Molar mass | 563.687 g/mol |
Except where otherwise noted, data are given for materials in their
standard state
(at 25
°C [77
°F], 100
kPa).
|
Dihydroergocornine is an ergot alkaloid . Alongside dihydroergocristine and dihydroergocryptine , it is one of the three components of ergoloid . [1]
References
- ↑ Steinhilber D, Schubert-Zsilavecz M, Roth HJ (2005). Medizinische Chemie (in German). Stuttgart, Germany: Deutscher Apotheker Verlag. p. 142. ISBN 3-7692-3483-9 .
![]() |
This drug article relating to the cardiovascular system is a stub . You can help Wikipedia by expanding it . |